| Website | invescoperpetual.... |
| Phone | 44 1491 417 000 |
| enquiry@invescope... | |
| Employees | |
| Description | private equity |
Invesco Perpetual is a holding company. Through its subsidiaries, the company is engaged in the management and dealing of authorized unit trusts; management of individual savings accounts and personal equity plans; management of investment portfolios; provision of financial consulting services; property development, and investment holding.
| Company | Date | Round | Size | Participants |
| Xeros | 3/13 | Venture Round | £10M | 6 |
| Glide Pharma | 2/13 | Private Equity | £14M | 1 |
| Lamellar Biomedical | 1/13 | Series A | £3.3M | 4 |
| Cell Medica | 7/12 | Venture Round | £17M | 3 |
| Oxford Immunotec | 6/12 | Venture Round | $28M | 8 |
| Nexeon | 8/11 | Venture Round | £40M | 2 |
| Oxford Nanopore Technologies | 4/11 | Series D | £25M | 3 |
| Oxford Nanopore Technologies | 4/10 | Series C | $28M | 4 |